Zhejiang Vie Science & Technology Co Ltd
Zhejiang VIE Science & Technology Co., Ltd. engages in the research and development, production, and sale of automotive chassis control systems in China and internationally. It offers passenger car and commercial vehicle chassis control systems, including chassis front and rear suspension systems, automotive electronic control systems, pneumatic brake systems, hydraulic brake systems, clutch cont… Read more
Zhejiang Vie Science & Technology Co Ltd (002590) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.045x
Based on the latest financial reports, Zhejiang Vie Science & Technology Co Ltd (002590) has a cash flow conversion efficiency ratio of 0.045x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥140.70 Million) by net assets (CN¥3.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Vie Science & Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Zhejiang Vie Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Vie Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Vie Science & Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Weihai Huadong Automation Co Ltd
SHE:002248
|
0.044x |
|
Hefei Fengle Seed Co Ltd
SHE:000713
|
0.122x |
|
SK IE Technology Co Ltd
KO:361610
|
0.003x |
|
Nilfisk Holding A/S
CO:NLFSK
|
0.061x |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
|
-0.034x |
|
Monro Muffler Brake Inc
NASDAQ:MNRO
|
0.029x |
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
0.252x |
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SHG:688505
|
0.019x |
Annual Cash Flow Conversion Efficiency for Zhejiang Vie Science & Technology Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Vie Science & Technology Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.01 Billion | CN¥247.45 Million | 0.082x | -28.10% |
| 2023-12-31 | CN¥2.35 Billion | CN¥269.55 Million | 0.115x | +222.24% |
| 2022-12-31 | CN¥2.04 Billion | CN¥72.49 Million | 0.036x | +46.38% |
| 2021-12-31 | CN¥1.99 Billion | CN¥48.34 Million | 0.024x | -57.00% |
| 2020-12-31 | CN¥2.00 Billion | CN¥113.04 Million | 0.056x | -44.88% |
| 2019-12-31 | CN¥1.97 Billion | CN¥202.17 Million | 0.102x | -20.14% |
| 2018-12-31 | CN¥1.83 Billion | CN¥235.13 Million | 0.128x | +52.46% |
| 2017-12-31 | CN¥1.89 Billion | CN¥159.26 Million | 0.084x | +13.65% |
| 2016-12-31 | CN¥1.77 Billion | CN¥131.20 Million | 0.074x | -65.40% |
| 2015-12-31 | CN¥845.51 Million | CN¥180.90 Million | 0.214x | +94.34% |
| 2014-12-31 | CN¥765.85 Million | CN¥84.31 Million | 0.110x | +167.91% |
| 2013-12-31 | CN¥698.33 Million | CN¥28.70 Million | 0.041x | -62.07% |
| 2012-12-31 | CN¥662.24 Million | CN¥71.74 Million | 0.108x | +227.81% |
| 2011-12-31 | CN¥660.71 Million | CN¥-56.00 Million | -0.085x | -137.08% |
| 2010-12-31 | CN¥287.17 Million | CN¥65.65 Million | 0.229x | -70.72% |
| 2009-12-31 | CN¥185.72 Million | CN¥144.98 Million | 0.781x | +16.13% |
| 2008-12-31 | CN¥130.84 Million | CN¥87.95 Million | 0.672x | -- |